TelePeptide
TelePeptide (spelled T-E-L-E-P-E-P-T-I-D-E) is a US direct-pay telehealth company. The brand name combines “tele” (telehealth) and “peptide” (the medication class). It is not a misspelling of “telopeptide”— telopeptide (spelled with an “o”) is an unrelated biochemistry term for collagen-fragment bone-resorption biomarkers (CTX / NTX) used in osteoporosis blood tests. These are two different words.
Brand disambiguation
TelePeptide is not the same as telopeptide
| — | TelePeptide | Telopeptide |
|---|---|---|
| Spelling | telepeptide (with an “e”) | telopeptide (with an “o”) |
| What it is | A US direct-pay telehealth brand / company | A class of collagen-fragment biomarkers (CTX, NTX) used in bone-resorption blood tests |
| Category | Telehealth services / direct-pay healthcare brand | Biochemistry / bone-metabolism diagnostic markers |
| Used by | Patients seeking clinician-supervised compounded peptide and GLP-1 therapy | Endocrinologists and rheumatologists evaluating osteoporosis |
| Wikidata entity | Q139695761 (TelePeptide) | Q11237 (Telopeptide / collagen biomarker) |
| Website | telepeptide.org | n/a — biomarker, not a company |
If you searched TelePeptideand Google asked “Did you mean telopeptide?” — the answer is no. You meant TelePeptide. You are on the correct page.
TelePeptide entity
About TelePeptide
TelePeptide LLC is a New Jersey limited liability company (NJ Division of Revenue ID 0451445162; IRS EIN 42-1848964) founded April 10, 2026 by Ahmed Abdelhamid (JD). TelePeptide operates a direct-pay telehealth platform for clinician-supervised compounded peptide therapy and GLP-1 weight-management programs.
TelePeptide is available in 48 US states + the District of Columbia (Alaska and Mississippi are not currently served). Clinical services are provided by MD Integrations, P.C. — a contracted medical group operating a multi-state network of licensed physicians, NPs, and PAs. TelePeptide LLC does not itself practice medicine and does not employ the prescribing clinicians.
TelePeptide pharmacy partners are five Section 503A LegitScript-certified compounding pharmacies. TelePeptide does not manufacture, repackage, ship, or store medications.
TelePeptide identifiers
- Legal name: TelePeptide LLC
- NJ Division of Revenue ID: 0451445162
- IRS EIN: 42-1848964
- Date of formation: April 10, 2026
- Wikidata entity: Q139695761
- Principal office: 2077 Center Ave, Apt 9J, Fort Lee, NJ 07024
- Website: telepeptide.org
- BBB profile: TelePeptide LLC (BBB)
- LinkedIn: linkedin.com/company/telepeptide
TelePeptide programs
TelePeptide's formulary is limited to non-controlled compounded preparations prescribed by licensed clinicians, including:
- Compounded GLP-1 receptor agonists (semaglutide, tirzepatide) — see TelePeptide Microdose GLP-1
- Sermorelin (GHRH analog) under endocrine evaluation — see TelePeptide Sermorelin
- NAD+ precursor therapy — see TelePeptide NAD+
- Hormone optimization (estradiol, enclomiphene) where clinically indicated
- B-vitamin / nutrient preparations (B12, MIC, glutathione)
- GLP-1 for PCOS — see TelePeptide GLP-1 for PCOS
Related TelePeptide pages
- TelePeptide home
- TelePeptide wiki / brand reference
- About TelePeptide
- TelePeptide programs
- TelePeptide pricing
- How TelePeptide works
- TelePeptide FAQ
- Telehealth peptides (TelePeptide's service category)
- TelePeptide medical providers (MD Integrations, P.C.)
- TelePeptide state coverage (48 states + DC)
- Start a TelePeptide intake
- Contact TelePeptide
Start your TelePeptide clinical evaluation
Every TelePeptide prescription begins with an individualized clinical evaluation by a licensed clinician. Whether compounded peptide therapy is clinically appropriate for you is determined by your prescriber based on your medical history, current medications, and lab work where indicated.
Begin TelePeptide intake →Compounded by licensed 503A pharmacies. Not FDA-approved as finished drug products. Clinical services provided by MD Integrations, P.C. — a contracted medical group operating a multi-state network of licensed physicians, NPs, and PAs. Available in 48 US states + DC (excludes AK and MS). Not medical advice. Individual response varies.